From the Department of Diagnostic Radiology, American University of Beirut Medical Center, PO Box 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon (C.S., F.E.); Department of Radiology, Campbelltown Public Hospital, Campbelltown, NSW, Australia (A.M.); Discipline of Medical Radiation Sciences, University of Sydney, Lidcombe, NSW, Australia (P.C.B.); and Department of Diagnostic Radiology, Johns Hopkins Hospital, Baltimore, Md (D.Y.).
Radiology. 2016 May;279(2):571-7. doi: 10.1148/radiol.2015150511. Epub 2015 Dec 1.
To investigate opacification of head and neck vasculature during computed tomography (CT) of supraclavicular lymph nodes with a quadruple-phase contrast media and saline dual-injection protocol.
This retrospective study was institutional review board approved. In 180 consecutive patients, routine head and neck CT was performed with one of two protocols: protocol A, craniocaudal scan direction with 100 mL of contrast material injected intravenously as a single bolus; or protocol B, 100 mL of contrast material injected in four phases (phases 1-2, 60 mL of contrast material and saline injected at 2.5 mL/sec; phases 3-4, 40 mL of contrast material and saline injected at 2.5 mL/sec); both protocols had a fixed scan delay of 70 seconds. Attenuation of supraclavicular arteries and veins was measured with arteriovenous contrast ratio (AVCR) and contrast-to-noise ratio (CNR). Effective dose was calculated. Data were compared with the two-sample t test. Receiver operating characteristic (ROC) and visual grading characteristic analyses were performed.
Arterial attenuation was up to 20% higher (P < .05) after protocol B (mean ± standard deviation, 234.5 HU ± 33.2) than protocol A (160.0 HU ± 29.5). Venous system attenuation was significantly lower in protocol B (164.0 HU ± 17.0) than in protocol A (664.0 HU ± 12.0), with up to a 75% reduction (P < .0001). Protocol B generated significant (P < .0001) improvements in AVCR at multiple anatomic sites. At all anatomic levels, mean CNR with protocol B (34.4 HU ± 9.0) was significantly higher than that with protocol A (14.5 HU ± 14.0) (P < .0313). Effective dose was significantly reduced with protocol B (2.6 mSv ± 0.4 vs 3.2 mSv ± 0.8 with protocol A; P < .0041). ROC analysis demonstrated significantly higher area under the ROC curve for protocol B (P < .0022), with interreader agreement increasing from poor to excellent in lymph node visualization.
Significant improvement in lymph node visualization at the cervicothoracic junction is achieved with a quadruple-phase contrast media injection protocol.
探讨在锁骨上淋巴结 CT 检查中,使用四重期对比剂和盐水双重注射方案对头部和颈部血管的混浊情况。
这项回顾性研究得到了机构审查委员会的批准。在 180 例连续患者中,常规进行头颈部 CT 检查,使用以下两种方案之一:方案 A,顺行扫描方向,静脉内注射 100 毫升对比剂作为单次推注;或方案 B,4 期注射 100 毫升对比剂和盐水(阶段 1-2,以 2.5 毫升/秒注射 60 毫升对比剂和盐水;阶段 3-4,以 2.5 毫升/秒注射 40 毫升对比剂和盐水);两种方案的固定扫描延迟时间均为 70 秒。用动静脉对比比(AVCR)和对比噪声比(CNR)测量锁骨上动脉和静脉的衰减。计算有效剂量。数据采用两样本 t 检验进行比较。进行了接收器操作特性(ROC)和视觉分级特征分析。
方案 B(平均 ± 标准偏差,234.5 HU ± 33.2)后动脉衰减高达 20%(P <.05),而方案 A(160.0 HU ± 29.5)则更高。与方案 A 相比,方案 B 中的静脉系统衰减明显降低(164.0 HU ± 17.0),减少了高达 75%(P <.0001)。方案 B 在多个解剖部位产生了显著的(P <.0001)AVCR 改善。在所有解剖水平上,方案 B 的平均 CNR(34.4 HU ± 9.0)均显著高于方案 A(14.5 HU ± 14.0)(P <.0313)。方案 B 的有效剂量明显降低(2.6 mSv ± 0.4 与方案 A 的 3.2 mSv ± 0.8;P <.0041)。ROC 分析表明,方案 B 的 ROC 曲线下面积显著更高(P <.0022),读者间的一致性从淋巴结可视化的差到优增加。
在锁骨上淋巴结 CT 检查中,使用四重期对比剂注射方案可显著提高颈胸交界处淋巴结的可视化效果。